International Clinical Trial: Y-6 Sublingual Tablets for the Treatment of Acute Perforator Artery Territory Infarction

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129160) titled 'Y-6 Sublingual Tablets for the Treatment of Acute Perforator Artery Territory Infarction' on July 31.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University

Condition: Acute Perforator Artery Territory Infarction

Intervention: Phase 1 Control group:Y-6 Placebo Phase 1 Y-6 high-dose group:Y-6 sublingual tablets, 2 pieces Phase 1 Y-6 low-dose group:One Y-6 sublingual tablet and one Y-6 placebo Phase 2 Y-6 X-dose group:Y-6 sublingual tablets

Recruitment Status: Not Recruiting

Phase: 2-3

Date of First Enrollment: 2026-09-01

Target Sam...